Graham Capital Management »

Enanta Pharmaceuticals shares owned by Graham Capital Management

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $447k 37k 11.97
2025-06-30 $142k 19k 7.56
2025-03-31 $111k 20k 5.52
2023-12-31 $126k 13k 9.41

More positions owned by Graham Capital Management

Strategy Cl A New (MSTR)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Fidelity Wise Origin Bitcoin SHS Put Option (FBTC)
Eos Energy Enterprises Com Cl A Put Option (EOSE)
Purecycle Technologies Note 7.250% 8/1 (Principal)
Vaneck Etf Trust Gold Miners Etf (GDX)
Tilray Brands Note 5.200% 6/1 (Principal)
Sunrun Note 4.000% 3/0 (Principal)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Rivian Automotive Note 3.625%10/1 (Principal)

View all positions for Graham Capital Management

Top funds holding Enanta Pharmaceuticals

Farallon Capital Management
Krensavage Asset Management
Henderson Group
Vanguard Group
BlackRock
Millennium Management
Acadian Asset Management
Commodore Capital
Geode Capital Management
Renaissance Technologies
State Street Corporation
Stonepine Capital Management
Point72 Asset Management
Morgan Stanley
Marshall Wace

View all funds holding Enanta Pharmaceuticals